Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Journal Bearings01:23

Journal Bearings

1.2K
Journal bearings are mechanical components that support and provide lateral stability to rotating shafts and axles. They are crucial in reducing friction, wear, and vibration in machinery such as engines, turbines, and pumps. The principle behind journal bearings is forming a thin lubricant film between the bearing surface and the rotating shaft, which minimizes direct contact and reduces frictional forces.
To better understand the concept of journal bearings, consider a rope winch with dry or...
1.2K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

1.1K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.1K
Theoretical Approaches to Psychological Disorder01:29

Theoretical Approaches to Psychological Disorder

858
The development of psychological disorders, which are characterized by deviant, maladaptive, and personally distressing behaviors, has been explored through several theoretical approaches.
Biological approach
The biological approach posits that internal, organic factors are the primary causes of such disorders. This perspective emphasizes brain structure and function, genetic predispositions, and neurotransmitter imbalances. For example, schizophrenia has been associated with both genetic...
858
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

4.4K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.4K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

1.0K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.0K
Intrinsically Disordered Proteins02:18

Intrinsically Disordered Proteins

19.5K
Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
19.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

<i>AANA Journal</i> Course-GLP-1 Receptor Agonists: What CRNAs Need to Know About Their Expanding Role.

AANA journal·2026
Same author

<i>AANA Journal</i> Course-The Gut-Brain Axis and Chronic Pain: The Emerging Role of Microbiota.

AANA journal·2026
Same author

Implementation of a Pain Management Checklist to Improve Postoperative Pain in Adult Surgical Patients.

Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses·2026
Same author

Perioperative guidelines for peripheral nerve blocks.

Nursing·2026
Same author

Methadone or Buprenorphine: Equal in Treating Opioid Dependent Parturients?

AANA journal·2025
Same author

A Narrative, Qualitative Research Study of CRNA Perspectives of Practice Within the Anesthesia Care Team Model.

AANA journal·2025

Related Experiment Video

Updated: Feb 5, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.7K

AANA Journal Course--Optimizing Buprenorphine Induction: Updated Approaches in Opioid Use Disorder Management.

Michelle Canale1, Hannah Messenger2, Ruchama Barkai3

  • 1Assistant Professor, Assistant Dean, DNP in the Nurse Anesthesiology Program, and Director at University of South Florida, Tampa, Florida.

AANA Journal
|February 3, 2026
PubMed
Summary

Transitioning patients with opioid use disorder (OUD) to buprenorphine can be challenging. This review compares microdosing and bridging induction strategies to minimize withdrawal and improve patient comfort during OUD treatment.

Keywords:
buprenorphineinduction techniquemicrodosing and bridgingopioid use disorderprerequisite opioid withdrawal

More Related Videos

Transcriptomic Analysis of Human Retinal Surgical Specimens Using jouRNAl
10:32

Transcriptomic Analysis of Human Retinal Surgical Specimens Using jouRNAl

Published on: August 14, 2013

8.3K
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

5.6K

Related Experiment Videos

Last Updated: Feb 5, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.7K
Transcriptomic Analysis of Human Retinal Surgical Specimens Using jouRNAl
10:32

Transcriptomic Analysis of Human Retinal Surgical Specimens Using jouRNAl

Published on: August 14, 2013

8.3K
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

5.6K

Area of Science:

  • Pharmacology
  • Addiction Medicine
  • Clinical Pharmacy

Background:

  • Buprenorphine is a first-line treatment for opioid use disorder (OUD) due to its safety and efficacy.
  • Transitioning patients from full opioid agonists to buprenorphine presents clinical challenges, including managing withdrawal symptoms.
  • Current guidelines often require a period of mild-to-moderate opioid withdrawal before buprenorphine initiation, which can be difficult for patients.

Purpose of the Study:

  • To examine microdosing and bridging as buprenorphine induction strategies for patients with OUD.
  • To review the pharmacologic mechanisms of buprenorphine and compare induction techniques.
  • To explore regulatory and practical considerations for initiating buprenorphine in OUD management.

Main Methods:

  • Review of current literature on buprenorphine induction strategies for OUD.
  • Comparison of microdosing and bridging techniques based on patient comfort and withdrawal symptom management.
  • Analysis of pharmacologic properties of buprenorphine and its role in OUD treatment.

Main Results:

  • Microdosing and bridging have shown success in minimizing withdrawal symptoms during the transition to buprenorphine.
  • These strategies aim to improve patient comfort and adherence to OUD treatment.
  • Evidence-based guidance is emerging for safer and more effective buprenorphine initiation.

Conclusions:

  • Effective buprenorphine induction strategies are crucial for successful OUD treatment.
  • Microdosing and bridging offer promising approaches to manage the transition from full opioid agonists.
  • Further research and clinical guidance are needed to optimize buprenorphine initiation for OUD care.